Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

June 27, 2020

Review: The risk of contracting anthrax from spore-contaminated soil - A military medical perspective

European Journal of Microbiology & Immunology
Ernst-Jürgen FinkeHagen Frickmann
July 8, 2020
Case Report

Case Report of an Injectional Anthrax in France, 2012

Microorganisms
Jean-Marc ThouretJean-Nicolas Tournier
June 15, 2020
Preprint
Open Access

Structure of a dominant negative mutant reveals a stalled intermediate in anthrax protective antigen pore maturation

BioRxiv : the Preprint Server for Biology
H. ScottDerek J Taylor
June 2, 2020
Open Access

Direct Detection and Discrimination of Nucleotide Polymorphisms Using Anthraquinone Labeled DNA Probes

Frontiers in Chemistry
Sarah A GoodchildPhilip N Bartlett
May 21, 2020

Application of novel bacterial consortium for biodegradation of aromatic amine 2-ABS using response surface methodology

Journal of Microbiological Methods
Masoom FatimaRobina Farooq
June 11, 2020
Open Access

Atomic Structures of Anthrax Prechannel Bound with Full-Length Lethal and Edema Factors

Structure
Kang ZhouZ Hong Zhou
June 12, 2020

Latex content in the anthrax vaccine absorbed

The Journal of Allergy and Clinical Immunology. in Practice
Julie DavenportDerek Smith
July 14, 2020
Open Access

Anthrax Protective Antigen 63 (PA63): Toxic Effects in Neural Cultures and Role in Gulf War Illness (GWI)

Neuroscience Insights
Effie-Photini C TsilibaryApostolos P Georgopoulos
May 21, 2020
Open Access

A classification framework for Bacillus anthracis defined by global genomic structure

Evolutionary Applications
Spencer A BruceWendy C Turner
May 6, 2020
Review

Current State of Anthrax Vaccines and Key R&D Gaps Moving Forward

Microorganisms
Adam Clark, Daniel N Wolfe
May 6, 2020
Open Access

The Landscape of Anthrax Prevention and Control: Stakeholders' Perceptive in Odisha, India

International Journal of Environmental Research and Public Health
Krushna Chandra SahooDebdutta Bhattacharya

Sign up to follow this feed and discover related papers.

Related Feeds

AIDS Malignancies

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

© 2020 Meta ULC. All rights reserved
/feed-previews/anthrax/cae95b6d-f66b-4e93-b405-51887dd3a7cf